학술논문

More Than 50 Percent Reduction in LDL Cholesterol in Patients With Target LDL <70 mg/dL After a Stroke
Document Type
Academic Journal
Author
Amarenco, PierreLavallée, Philippa C.Kim, Jong S.Labreuche, JulienCharles, HugoGiroud, MauriceLee, Byung-ChulMahagne, Marie-HélèneMeseguer, ElenaNighoghossian, NorbertSteg, Philippe GabrielVicaut, ÉricBruckert, EricKim, Jong STouboul, Pierre-JeanLeys, DidierBéjot, YannickPico, FernandoTouzé, EmmanuelDucrocq, GregoryAbtan, JérémyVarenne, OlivierTouboul, Pierre-JeanKemmel, AgnesSyana, FaustaLedra, ManeleNagasara, TharaniLedjeroud, MervetteSamia, BahousHadia, HafirassouHazare, BenyoubJaghouni, Ikrame ElYelles, NessimaZemouri, SofiaLadjeroud, MervetteKerai, SalimIn, YunJeongHobeanu, CristinaGuidoux, CelineCabrejo, LucieLapergue, BertrandSabben, CandiceGonzalez-Valcarcel, JaimeRigual, RicardoSirimarco, GaiaMartin-Bechet, AnnaViedma, ElenaAvram, IoanSamson, YvesRosso, CharlotteCrozier, SophieLeder, SaraLéger, AnneDeltour, SandrineMutlu, GurkanYger, MarionZavanone, ChiaraBaronnet, FlorePires, ChristineLapergue, BertrandWang, AdrienEvrard, SergeTchikviladze, MayaBourdain, FrédéricLopez, DelphinePico, Fernandode la Tour, Laetitia BayonChadenat, Marie-LaureDuong, Duc LongGenty, SolèneHirel, CatherineMutlu, GurkanNifle, ChantalServan, JérômeStanciu, DanielaSudacevschi, VeronicaTir, MélissaTroussière, Anne-CécileYeung, JenniferZeghoudi, Anne-CélineTidafi-Bayou, IkramLachaud, SylvainCho, Tae-HeeMechtouff, LauraRitzenthaller, ThomasDerex, LaurentAlbanesi, CarloOng, ElodieBenoit, AmandineBerhoune, NadiaFelix, SandraEsteban-Mader, MaudSibon, IgorKazadi, AnnabelleRouanet, FrançoisRenou, PaulineDebruxelles, SabrinaPoli, MathildeSagnier, SharmilaMas, Jean-LouisDomigo, ValérieLamy, CatherineBodiguel, EricGrimaud, JérômeBohotin, ValentinObadia, MichaelSabben, CandiceMorvan, ErwanRodier, GillesVadot, WilfriedHénon, HildeCordonnier, CharlotteDumont, FrédéricBodenant, MarieLucas, ChristianMoulin, SolèneDequatre, NellyAlamowitch, SoniaMuresan, Jean-PaulDrouet, ThomasGallea, MagalieDalloz, Marie-AmélieDelorme, StephenYger, MarionBéjot, YannickLoisel, PhilippeBonnin, CarineBernigal, VirginieOsseby, Guy VictorHervieu-BègueMarsac, MarieGarnier, PierreAccassat, SandrineEpinat, MagaliVarvat, JérômeMarinescu, DoïnaTriquenot-Bagan, AudeOzkul- Wermester, OzlemPhilippeau, FrédéricOlaru, AngelVieillart, AnneLannuzel, AnnieDemoly, AliceWolff, ValérieDiaconu, MihaelaBataillard, MarcMontoro, Francisco MacianFaugeras, FrédéricGimenez, LaeticiaAbdallah-Lebeau, FrançoiseTimsit, SergeViakhireva-Dovganyuk, IrinaTirel-Badets, AnneMerrien, François-MathiasGoas, PhilippeRouhart, FrançoisJourdain, AuroreGuillon, BenoitHérissson, FannySevin-Allouet, MathieuNasr, NathalieOlivot, Jean-MarcLecluse, AldericMarc, GuillaumeTouzé, Emmanuelde la Sayette, VincentApoil, MarionLin, LiCogez, JulienGuettier, SophieGodefroy, OlivierLamy, ChantalBugnicourt, Jean-MarcTaurin, GrégoryMérienne, MarcGere, JulienChessak, Anne-MarieHabet, TarikFerrier, AnnaBourgois, NathalieMinier, DominiqueCaillier-Minier, MarieContégal- Callier, FabienneVion, PhilippeVaschalde, YvanAmrani, Mohammed ElEmilieZuber, MathieuBruandet, MarieJoin- Lambert, ClaireGarcia, Pierre-YvesSerre, IsabelleFaucheux, Jean-MarcRadji, FatiaLeca-Radu, ElenaDebroucker, ThomasCumurcuc, RodicaCakmak, SerkanPeysson, StéphaneEllie, EmmanuelBernady, PatriciaMoulin, ThierryMontiel, PaolaRevenco, EugeniuDecavel, PierreMedeiros, ElisabethBouveret, MyriamLouchart, PierreVaduva, ClaudiaCouvreur, GrégorySartori, EricCarpentier, AlnajarLevasseur, MichèleLouchart, PierreFaucheux, Jean-MarcNeau, PhilippeVandamme, XavierMeresse, IsabelleStantescuBataillard, MarcOzsancak, CananBeauvais, KatellAuzou, PascalAmevigbe, JoséphineVuillemet, FrancisDugay-Arentz, Marie-HélèneCarelli, GabrielaMartinez, MikelMaillet-Vioud, MarcelEscaillas, Jean-PierreChapuis, StéphaneTardy, JeanManchon, EricVarnet, OlivierKim, Yong-JaeChang, YoonkyungSong, Tae-JinKim, Jong SungHan, Jung-HoonNoh, Kyung ChulLee, Eun-JaeKang, Dong-WhaKwon, Sun UckKwon, BoseoungPark, SeonghoLee, DongwhaneKwon, Hyuk SungJeong, DaeunLee, MinHwanKim, JoonggooLee, HanbinNam, Hyo JungLee, Sang HunKim, Bum JoonCha, Jae-kwanKim, DaeHyunKim, Rae YoungSohn, Sang WukShim, Dong-HyunLee, HyungjinNah, Hyun-WookSung, Sang MinLee, Kyung BokYoon Lee, JeongYoon, Jee EunKim, Eung-GyuSeo, Jung HwaKim, Yong-WonHwang, YanghaPark, Man SeokKim, Joon-TaeChoi, Kang-HoNam, Hyo SukHeo, Ji HoeKim, Young DaeHwang, In GunPark, Hyung JongKim, Kyoung SubBaek, Jang HyunSong, Dong BeomYoo, Joon SangPark, Jong-MooKwon, OhyunLee, Woong-WooLee, Jung-JuKang, KyusikKim, Byung KunLim, Jae-SungOh, Mi SunYu, Kyung-HoHong, BoraJang, MihoonJang, SeyoungJin, Jung EunKim, JeiJeong, Hye SeonHong, Keun SikPark, Hong KyunCho, Yong JinBang, Oh YoungSeo, Woo-KeunChung, Jongwon
Source
Stroke. Aug 01, 2023 54(8):1993-2001
Subject
Language
English
ISSN
0039-2499
Abstract
BACKGROUND:: Whether a strategy to target an LDL (low-density lipoprotein) cholesterol <70 mg/dL is more effective when LDL is reduced >50% from baseline rather than <50% from baseline has not been investigated. METHODS:: The Treat Stroke to Target trial was conducted in France and South Korea in 61 sites between March 2010 and December 2018. Patients with ischemic stroke in the previous 3 months or transient ischemic attack within the previous 15 days and evidence of cerebrovascular or coronary artery atherosclerosis were randomly assigned to a target LDL cholesterol of <70 mg/dL or 100±10 mg/dL, using statin and/or ezetimibe as needed. We used the results of repeated LDL measurements (median, 5 [2–6] per patient) during 3.9 years (interquartile range, 2.1–6.8) of follow-up. The primary outcome was the composite of ischemic stroke, myocardial infarction, new symptoms requiring urgent coronary or carotid revascularization, and vascular death. Cox regression model including lipid-lowering therapy as a time-varying variable, after adjustment for randomization strategy, age, sex, index event (stroke or transient ischemic attack), and time since the index event. RESULTS:: Among 2860 patients enrolled, patients in the lower target group who had >50% LDL cholesterol reduction from baseline during the trial had a higher baseline LDL cholesterol and a lower LDL cholesterol achieved as compared to patients who had <50% LDL cholesterol reduction (155±32 and 62 mg/dL versus 121±34 and 74 mg/dL, respectively, P<0.001 for both). In the <70 mg/dL target group, patients with >50% LDL reduction had a significant reduction in the primary outcome as compared to the higher target group (hazard ratio, 0.61 [95% CI, 0.43–0.88]; P=0.007) and patients with <50% LDL reduction from baseline had little reduction (hazard ratio, 0.96 [95% CI, 0.73–1.26]; P=0.75). CONCLUSIONS:: In this post hoc analysis of the TST trial, targeting an LDL cholesterol of <70 mg/dL reduced the risk of primary outcome compared with 100±10 mg/dL provided LDL cholesterol reduction from baseline was superior to 50%, thereby suggesting that the magnitude of LDL cholesterol reduction was as important to consider as the target level to achieve. REGISTRATION:: URL: https://www.clinicaltrials.gov; Unique identifier: NCT01252875. URL: https://clinicaltrialsregister.eu; Unique identifier: EUDRACT2009-A01280-57.